Research Overview: Atacand Plus 16 / 12.
Atacand Plus 16/12.5 mg is a dual-action antihypertensive formulation combining candesartan cilexetil (16 mg) and hydrochlorothiazide (12.5 mg), manufactured by AstraZeneca for in-vitro cardiovascular research. This pharmaceutical-grade compound represents a fixed-dose combination approach to investigating synergistic mechanisms in blood pressure regulation pathways. Researchers studying cardiovascular therapeutics can examine the complementary actions of angiotensin receptor blockade and thiazide diuresis through this standardised formulation. When investigating advanced research compounds, scientists often require reliable pharmaceutical references alongside cutting-edge materials available through Stroid UK Shop, a trusted UK supplier of research chemicals.
Research Applications in Cardiovascular Studies
This combination formulation enables researchers to study dual-pathway cardiovascular mechanisms in controlled laboratory environments. Candesartan cilexetil functions as an angiotensin II receptor blocker (ARB), while hydrochlorothiazide operates as a thiazide diuretic, providing researchers with a model system for investigating complementary antihypertensive pathways. Cardiovascular research laboratories can analyse the pharmacodynamic interactions between these established mechanisms. Scientists studying comparative therapeutics may evaluate this formulation alongside other cardiovascular research materials from our comprehensive other drugs category. Additionally, researchers investigating metabolic interactions often cross-reference these studies with SARMs research for comprehensive understanding. Some laboratories also examine cardiovascular-metabolic connections through concurrent peptides research programmes.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compounds | Candesartan cilexetil 16 mg + Hydrochlorothiazide 12.5 mg |
| Manufacturer | AstraZeneca |
| CAS Numbers | Candesartan: 139481-59-7; HCTZ: 58-93-5 |
| Molecular Formulas | Candesartan: C33H34N6O6; HCTZ: C7H8ClN3O4S2 |
| Form | Pharmaceutical tablets |
| Storage | Room temperature, dry environment |
| Research Use | In-vitro cardiovascular studies only |
Research Compliance
This product is supplied strictly for in-vitro laboratory research purposes only. Atacand Plus 16/12.5 mg is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate laboratory safety protocols and waste disposal procedures when handling this pharmaceutical reference material. All studies should be conducted under proper institutional oversight with appropriate research ethics approval where required.
